| The cerebrospinal fluid in multiple sclerosis F Deisenhammer, H Zetterberg, B Fitzner, UK Zettl Frontiers in immunology 10, 726, 2019 | 220 | 2019 |
| Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients B Fitzner, M Hecker, UK Zettl Autoimmunity reviews 14 (10), 903-913, 2015 | 91 | 2015 |
| High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients M Hecker, B Fitzner, M Wendt, P Lorenz, K Flechtner, F Steinbeck, ... Molecular & cellular proteomics 15 (4), 1360-1380, 2016 | 88 | 2016 |
| Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid R Jaster, I Hilgendorf, B Fitzner, P Brock, G Sparmann, J Emmrich, ... Biochemical pharmacology 66 (4), 633-641, 2003 | 85 | 2003 |
| Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment T Schwaiger, C van den Brandt, B Fitzner, S Zaatreh, F Kraatz, A Dummer, ... Gut 63 (3), 494-505, 2014 | 84 | 2014 |
| Peroxisome proliferator‐activated receptor γ overexpression inhibits pro‐fibrogenic activities of immortalised rat pancreatic stellate cells R Jaster, P Lichte, B Fitzner, P Brock, Ä Glass, T Karopka, L Gierl, ... Journal of cellular and molecular medicine 9 (3), 670-682, 2005 | 81 | 2005 |
| Senescence determines the fate of activated rat pancreatic stellate cells B Fitzner, S Müller, M Walther, M Fischer, R Engelmann, B Müller‐Hilke, ... Journal of cellular and molecular medicine 16 (11), 2620-2630, 2012 | 78 | 2012 |
| Generation and characterization of immortalized rat pancreatic stellate cells G Sparmann, C Hohenadl, J Tornøe, R Jaster, B Fitzner, D Koczan, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 287 (1 …, 2004 | 78 | 2004 |
| Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells A Karger, B Fitzner, P Brock, G Sparmann, J Emmrich, S Liebe, R Jaster Cellular signalling 20 (10), 1865-1872, 2008 | 71 | 2008 |
| Galectin-1 is an inductor of pancreatic stellate cell activation B Fitzner, H Walzel, G Sparmann, J Emmrich, S Liebe, R Jaster Cellular signalling 17 (10), 1240-1247, 2005 | 64 | 2005 |
| Transforming growth factor-β induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5 pathway SL Haas, SL Haas, B Fitzner, SL Haas, B Fitzner, R Jaster, E Wiercinska, ... Growth Factors 27 (5), 289-299, 2009 | 59 | 2009 |
| Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells R Bülow, B Fitzner, G Sparmann, J Emmrich, S Liebe, R Jaster Biochemical pharmacology 74 (12), 1747-1757, 2007 | 54 | 2007 |
| Mathematical modelling of interferon-γ signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity K Rateitschak, A Karger, B Fitzner, F Lange, O Wolkenhauer, R Jaster Cellular signalling 22 (1), 97-105, 2010 | 52 | 2010 |
| Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis J Friess, M Hecker, L Roch, D Koczan, B Fitzner, IC Angerer, I Schröder, ... Scientific reports 7 (1), 42087, 2017 | 46 | 2017 |
| Inhibitory effects of interferon-γ on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression B Fitzner, P Brock, H Nechutova, Ä Glass, T Karopka, D Koczan, ... Cellular signalling 19 (4), 782-790, 2007 | 46 | 2007 |
| Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells B Fitzner, P Brock, SA Holzhüter, H Nizze, G Sparmann, J Emmrich, ... Digestive diseases and sciences 54, 309-320, 2009 | 40 | 2009 |
| Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach F Lange, K Rateitschak, B Fitzner, R Pöhland, O Wolkenhauer, R Jaster Molecular cancer 10, 1-13, 2011 | 38 | 2011 |
| Systematic review of studies on telomere length in patients with multiple sclerosis J Bühring, M Hecker, B Fitzner, UK Zettl Aging and disease 12 (5), 1272, 2021 | 35 | 2021 |
| Leukocyte telomere length in patients with multiple sclerosis and its association with clinical phenotypes M Hecker, B Fitzner, K Jäger, J Bühring, M Schwartz, A Hartmann, ... Molecular Neurobiology 58, 2886-2896, 2021 | 35 | 2021 |
| Genetic, environmental and lifestyle determinants of accelerated telomere attrition as contributors to risk and severity of multiple sclerosis M Hecker, J Bühring, B Fitzner, PS Rommer, UK Zettl Biomolecules 11 (10), 1510, 2021 | 32 | 2021 |
Robert JasterVerified email at med.uni-rostock.de
